Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2015

Open Access 01-12-2015 | Poster presentation

MRI evaluation of multifocality and contralateral disease in lobular breast cancer: what can we learn from one region's experience?

Authors: Claire Magee, Keith Lowry

Published in: Breast Cancer Research | Special Issue 1/2015

Login to get access

Excerpt

Invasive lobular cancer has been associated with an increased risk of multifocal and contralateral disease. The literature suggests an incidence of contralateral disease as high as 15%. Current national (NICE) recommendations are that all patients with lobular carcinoma being considered for breast-conserving surgery have a preoperative breast MRI. The objective was to identify the rate of additional MRI-detected multifocal and contralateral disease in patients with a newly diagnosed lobular cancer to determine whether it is as high as the literature suggests. Based on our findings we hope to further explore whether another imaging alternative should be considered. …
Metadata
Title
MRI evaluation of multifocality and contralateral disease in lobular breast cancer: what can we learn from one region's experience?
Authors
Claire Magee
Keith Lowry
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2015
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3770

Other articles of this Special Issue 1/2015

Breast Cancer Research 1/2015 Go to the issue

Poster presentation

Can public consultation effectively optimise the design of a patient information leaflet about breast magnetic resonance imaging?

Poster presentation

Follow-up imaging of breast symptomatic patients: a waste of radiologist time?

Oral presentation

Breast screening interval and the characteristics of screen-detected cancers

Poster presentation

Safety of vacuum-assisted biopsy/mammatome guided, non-operative management of B3 lesions without atypia: a 7-year follow-up study

Poster presentation

Comparative study of radiation dose between tomosynthesis and standard compression views in mammography

Poster presentation

A comparative study of pathological and prognostic differences in DCIS between Asian and Caucasian women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits